Durham, NC 的 胰臟癌 臨床試驗
24 項針對 胰臟癌 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
招募中3 期
- Duke Cancer Center, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 距離 13 英里
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
招募中3 期
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US035, Chapel Hill · 距離 10 英里
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
招募中
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中觀察性研究
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
- University of North Carolina-Hillsborough Campus, Hillsborough · 距離 13 英里
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 距離 10 英里
- University of North Carolina, Chapel Hill · 距離 10 英里
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
招募中1 期
- Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
招募中2 期
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
招募中1 期
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
招募中1/2 期
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
招募中2 期
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距離 10 英里
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
其他城市的 胰臟癌 試驗
- Houston, TX61 項研究
- New York City, NY60 項研究
- Boston, MA43 項研究
- Nashville, TN39 項研究
- Los Angeles, CA35 項研究
- St. Louis, MO33 項研究
- Arlington, VA33 項研究
- Baltimore, MD31 項研究
- San Antonio, TX31 項研究
- Philadelphia, PA26 項研究
- Tampa, FL26 項研究
- San Diego, CA24 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。